Preimplantation genetic testing legislation and accessibility in the Nordic countries
- 26 February 2020
- journal article
- research article
- Published by Wiley in Acta Obstetricia et Gynecologica Scandinavica
- Vol. 99 (6), 716-721
- https://doi.org/10.1111/aogs.13831
Abstract
Introduction Assisted Reproduction Technologies are in rapid development and implementation of preimplantation genetic testing (PGT) has allowed patients with genetic disorders to initiate pregnancies while minimizing or eliminating the risk of transmitting these disorders to their offspring. Testing for numeric chromosomal anomalies has been proposed as a way to increase efficacy in assisted reproduction, however this remains disputed. Legislation is lagging behind the rapid developments in this field. Material and methods We conducted a structured online survey of legislation and accessibility to Preimplantation Genetic Testing in the Nordic countries to compare the regulation and uptake of this technique. The survey was designed and answered by the authors. Results Key elements in regulation of preimplantation testing for monogenic disorders and structural rearrangements are similar in the Nordic countries although accessibility varies since only Denmark, Finland and Sweden have national clinics offering treatment. In addition, Denmark and Finland have private clinics offering PGT. Regulation is most stringent in Norway where a national board evaluates all couples seeking treatment. Treatment volumes vary between the Nordic countries with Norway and Finland having lowest treatment numbers. Preimplantation genetic testing for aneuploidy in the embryo varies between the Nordic countries where Finland and Iceland are allowed to offer this form of treatment, Denmark and Sweden only in the form of a research protocol while this form of testing is not allowed at all in Norway. Therefore the number of treatment cycles involving testing for embryo aneuploidy are lower in the Nordic countries compared to other countries where this treatment option is more common. Conclusions Science needs to inform politics regarding the rapidly evolving field of reproductive medicine and we recommend harmonization of legislation and accessibility between the Nordic countries.Keywords
This publication has 24 references indexed in Scilit:
- Embryonic aneuploidy rates are equivalent in natural cycles and gonadotropin-stimulated cyclesFertility and Sterility, 2019
- The use of preimplantation genetic testing for aneuploidy (PGT-A): a committee opinionFertility and Sterility, 2018
- Blastocentesis: a source of DNA for preimplantation genetic testing. Results from a pilot studyFertility and Sterility, 2014
- Preimplantation genetic screening: back to the futureHuman Reproduction, 2014
- The nature of aneuploidy with increasing age of the female partner: a review of 15,169 consecutive trophectoderm biopsies evaluated with comprehensive chromosomal screeningFertility and Sterility, 2014
- Preimplantation genetic diagnosis for Huntington's disease with exclusion testingEuropean Journal of Human Genetics, 2002
- Preimplantation Diagnosis for Fanconi Anemia Combined With HLA MatchingJAMA, 2001
- Positive outcome after preimplantation diagnosis of aneuploidy in human embryos *Human Reproduction, 1999
- Simultaneous enumeration of chromosomes 13, 18, 21, X, and Y in interphase cells for preimplantation genetic diagnosis of aneuploidyCytogenetic and Genome Research, 1996
- Pregnancies from biopsied human preimplantation embryos sexed by Y-specific DNA amplificationNature, 1990